Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Company insiders (the Cotropias, Chandra and Harry) hold 395,180,000 Series B shares, so if those convert 1:10, ENZC could eliminate nearly 4 billion common shares of future dilution if alternative equity could be substituted.
That would still leave up to 1.35 billion shares yet to enter float, just from the instruments we currently have information about.
Quick correction to my last post. I said "5,310,745,365 new common shares" but I noticed that total includes the 380,289,565 restricted common that are already issued. (ie Those would not be "new" shares.)
More accurately, around 4,930,455,800 common shares might someday enter the float through conversion pathways and exercising of warrants. Up to 5,310,745,365 common shares that are not in the float now, may eventually enter the float.
Class B appears to be convertible 1:10 for common. Class C appears to be convertible 1:100 for common. Neither can currently result in significant dilution given the current O/S is 2,830,435,953 and the A/S is 3,000,000,000. So only ~170 Million new common shares can currently be created, which would be worth only $6.67 Million at today's prices.
You're right, we have no info on Class E, which are a convertible class.
I did an analysis in April and found conversion pathways for up to 5,310,745,365 new common shares, plus more from unknowns. If ENZC ever does a reverse split or increases A/S, that's when we'd need to be on the lookout for significant dilution.
In the meantime, the company says 380,289,565 of its restricted common shares "have met the SEC requirement for removal of the restrictive legends" so those could always enter the float imminently and have a dilutive effect.
A/S and O/S:
https://www.otcmarkets.com/stock/enzc/security
Company statement on outstanding restricted shares, Page 1:
https://www.otcmarkets.com/otcapi/company/financial-report/323613/content
Some parts of this DD are dated now, but the share structure hasn't changed significantly since April. Summary is toward the bottom of post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168639909
Class B conversion 1:10 to common from earlier filings:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168313089
MP...See-CDEL,VIRTU..ACCUSED..SPOOFING.BIOTECH.//-_BIOTECH SUING..CITADEL..OVER.MRKET,.MANIPULATION+-
_these are 2 of 3 articles in news from 12/1
MP ..question
IS there any evidence that can be sent as a contributer
and help widen this case ..with enzc scenarios
_see this 3rd article on Google
_
BIOTECH COMPANY SAYS CITADEL OTHER BIO TRADERS MANIPULATED ITS STOCK PRICE Bloomberg law
_
THESE ARE FOUND ONLINE DEC 1ST
CO IS
NORTHWEST BIOTHERAPEUTICS
_
These are stories recently out about taking legal action
Do we have attorneys in this stock to comment on this
Or
any holders also interested to get enzc experiences out..
Good that we closed green.....maybe news next week.
Sounds better.,than..a consult,.for..legal.,action..from..investors..to..me
Finance, in respect to your comment:
FTW ACTUALLY Found..your infm..as. confused..'infm..2x-lol..but.,your.,case..it's .good..enough.
But ..there are ways with reading daily and it does help with need to get up to speed with comprehension
I offer help on pm with this
They've been incurring R&D expenses according to the P&L's, so something is going on.
You thinking Christmas surprise? NPI won't answer their phone, probably literally rang off the hook.
DRHUMI, Agree… eom
Ive been thinking they are further into the trials than we know. I think Charles wanted a pass on 1 and 2 and then pick up at 3 to duplicate the previous results. They maybe close to the end we just have to wait.
shhhhh! The "strategy" here is to not consider false statements about ENZC being a scam…
Well.... As I suggested a couple months back, it appears they're gonna try to roll out plandemic19 again, just in time for Christmas... Of course this is NY, but that's where it always begins (I really feel sorry for anyone still buying into this crap with face diapers)...
Hopefully ENZC is prepared and doesn't miss the boat when they do....
Exactly what information do you have or know of that the auditors are lacking in order to complete the audit? Have you had contact with the auditors, or are you in a position to help the auditors find the missing information?
I never said he cares about shareholders at this point of the game - why should he? He might never care cause he does need us .
Yes, I've talked to my CEO to provide IPF Immune as a proactive step in keeping employees healthy. I know others who have shared Enzoimmune with their employees as they work with patients on a day to day basis.
Your post has all kinds of weird symbols and doesn't make much sense...so hopefully that answers your questions.
Timing,
If you go back and re-read my post, I was not talking about convertibility, but voting control.
Yes, I do know the difference. . .
It does not yet matter what the FDA does, the EUMA is the big first hurdle and then the FDA's refusal to honor the international Pandemic agreements will come after that.
But prior to that, a larger pharma partner will want to cash in on being first to market with this, and probably wind up in a licensing agreement, if not a company procurement.
My best prediction at present, if ENZC has working in Stage IV, what it's supposed to have working.
in the pinks and enzc we dont allow reality. we call that gloom and doom. thats forbidden
Why don't we all skip the anticipatory warning of gloom and doom statements because as the argument has been made that ENZC is just about out of money. If that is the case then the answer to the next question will be known and the gloom will either be out in the open at which point legal action will most certainly follow in short order or we'll all know where they'll get more money.from at that point. This is simple. ENZC is just about out of time on everyone's patience meter. Either shit or you'll be removed from the pot and face the music while investors face the music and attempt to recover via numerous means civil remedies. If they deliver then it'll all be a mute point and CC and the good Dr, will be heroes ! No need to continue day in and day out to slam the shortcomings of the company. You don't have to fake being an owner of ENZC shares and you can move on to the next assignment ! As far as Maga time and rock. Keep looking to the future and praying that CC gets the ship moving in the right direction. This has been very concerning for many reasons and that's why investing is risky ! That's why running a company comes with it's own risks for board members. Good luck to everyone. The ending for everyone is on the way and we will soon know if the company will survive or be put out to pasture by frustrated owners taking legal action. Save your opinions on success and failure because they are all meaningless and only facts will matter in determining the outcome. Frankly I like the comparison of CC to Santa !!! Wouldn't that be a great start to the new year. If I remember correctly. CC stated that the Vet partner and product to market would happen in the fourth quarter. We'll see?? I'm a long I'm disappointed and pissed off with the communication not coming from the company but I just like all the other true longs are still here and are still up big. I'm greedy and looking for one hell of a lot more !!
shhhhh! The "strategy" here is to not consider financials. here instead we hope for for big pharma to buy us out, so there is no time for those fancy numbers!
Are you talking about these disclosures (page 21 of the ENZC financials QTR 3 - 2022)?
Are you talking about these disclosures (page 21 of the ENZC financials QTR 3 - 2022)?
Super Majority Voting Rights. The record holders of the Series A Preferred Shares shall have the right to
vote on any matter with holders of common stock voting together as one (1) class. The record holders of
the Series A Preferred Shares shall have that number of votes (identical in every other respect to the voting
rights of the holders of other series of voting preferred shares and the holders of common stock entitled to
vote at any regular or special meeting of the shareholders) equal to that number of common shares which
is not less than 51% of the vote required to approve any action, which Delaware law provides may or must
be approved by vote or consent of the holders of other series of voting preferred shares and the holders of
common shares or the holders of other securities entitled to vote, if any. For purposes of determining the
number of votes, each one (1) share of the Series A Preferred shall have voting rights equal to (x) 0.019607
multiplied by the total issued and outstanding common stock eligible to vote at the time of the respective
vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator.
Hint: I did read them. And did the calculations. What did you come up with?
IF WE ONLY HAD ENOUGH DISCLOSURE. . .
Mineanddine, IF we had all of the disclosure on convertibility, we could figure out just how much conversion of preferred stock could possibly be coming. But, with only about 1.7M shares still left to issue of common stock of the 3.0 Billion shares authorized, IMO EMZC will continue to issue bits and pieces of short-term/medium-term notes payable that will carry a conversion feature. Then ENZC could do its magic to pump the stock price (More fake PR's and RSI resets) to get rid of the debt and accrued interest at a later date. That has been its pattern thus far (for years). But, the way they handled prior debt with the 251(g) merger in DE, it got them into a lawsuit with Cimarron, et al.
We will hide and watch thatone. . .
You know I thought it was strange Dr Chandra has not been on Twitter since Aug of this year.
--
Then I noticed he is very active on his Linked In Profile with comments ranging from Yuan , to other topics to the AI that Kirsten Bischof is working on .
--
see link
https://www.linkedin.com/in/gaurav-chandra-md-mba-a8964b74/recent-activity/
But..Is being.,factual..and.in,,fact...knowing.,ahead...Important.,here
I believe this is the case. They're almost out of cash. Where will it come from?
Drama… “THERE IS DILUTION COMING. . . “
THERE IS DILUTION COMING. . .
Dyno89, you need to read the footnotes to the last Qtr. financials. The Class B & C Preferred Stock is convertible! ENZC has chosen not to tell us what the conversion rates are. They only say that the conversion is there under the terms of what they have filed with the State of DE. Isn't that just a wonderful case of transparency?
ENZC has also recently issued a Serie E Class of preferred stock. Interestingly enough, the the Qtr. financials nothing is even mentioned about this issuance. It just shows on the balance sheet. Another blown disclosure.
IMO, all of the common shareholders should prepare for a significant dilution through conversion of preferred shares OR by reverse split of common. That is the only way ENZC can get any shares available to stay liquid in the future. It would be suicide to authorize more common shares.
Hide and watch!
Listening to opinions presented as fact is never a good investing strategy, Denial of false claims of scams is a very good, very profitable investing/trading strategy “Denial has never been a successful investing strategy!”
WC What's in it this season//enzc memorabilia
Specifically what information is lacking? You obviously know what information is lacking?
FTW SAYIN,verified..? WITH/CEO.. WHEN...FDA-approves.'pkg..TV..ADV'..Come,,'with..$.attn to product and stock .
After seeing avail deals to distribute with your own co.
Assuming this was when at the ERM marketing meets with retailers
Is this correct?
Also watching TV ads gives clarity to claim of scam.. theories
Hmm..ohh
Hey..now is this..you..ps..sure.,seems..lol ..and..many..if..thankful..+
in the scope of schemes and terms like it ..there is another possible idea ..on this topic shown multi/ day and some times multi/ hr.
For a what could that amt, of frequency tell..
if it becomes confusing ..
Point made
Here is a
Next idea ..as of yet not done ..
Do any reading here..?
have a photo of a muzzled dog for use with any newer illustrations to help with .. getting some effective visuals to attempt better traction or anything like it for intended goals.
Timing you need to chime in today...got anything new ?
Tenacious posting - you make some valid points and you really go after it with such spirit, thank you.
I wouldn't get your hopes up rockie.... Nothing has changed... I still expect them to drive us down to .025ish to close out December. If/when we begin to see some urgency around the buying, we can start getting excited, but anything prior to that, you're just asking for more disappointment.
As it stands right now, we're looking at 5 days (next week 12/12-12/17) where we could see something. Once we're past that, we're way to close to Christmas/New years, and seriously doubt they'd drop anything significant. However, based on today's action so far, I'm pretty sure we can rule out Monday, and maybe even Tuesday, leaving us with Wed-Fri. My point being that we are quickly running out of time for them to break their Over Promise-under deliver 1,000 batting avg for 2022. At this point, the best we can hope for this year is another fluff PR where we're told for the X-teenth time that "the audit is almost complete and they are finalizing it..." LOL...
The only folks who will buy it are shareholders imo. That’s the way these pink products work, and how they’re (not) marketed to the masses. Like the “iwand” and OPTI.
It's not even negative. It's constructive criticism, and it isn't even aimed at Enzolytics, although they have final say on the site. The site was the exact same when it rolled out in May, that's saved to the Wayback machine.
Then it went down with the "coming soon" site being there for 6 months, and they come back with the same site. My opinion is they need to scrap Synergy completely... 6 MONTHS and they didn't work on the site AT ALL.
You're right about word of mouth, it will sell, I just don't want that site burned in important people's minds reflecting on everything else they are doing.
How much money does GSK have to put lipstick on that pig?
Word of mouth will do much more for this product than the initial website...I'm not worried in the least, once FDA approves the label, then they can look at other items...ppl who know nothing about Enzolytics have been taking Enzoimmune....My Company and many other companies will look at IPF to supply to their traveling employees...I've already had initial conversations with the CEO...and asEnzolytics has stated they will have commercials and things, so your negative sentiment is unnecessary.
Or they can dilute to raise funds to make everything perfect to make the naysayers happy...I'm good with their approach on getting it to market and dealing with the other details with the initial revenue they bring in.
Be back in a week or two...GLTA
It doesn't matter what you or anyone here thinks. If people don't believe, they don't try the product. The fake testimonials along with the stock pictures of the Mary Poppins family are ATROCIOUS... The Light Blue lettering screams that they have no idea how to make a webpage, which is odd because Synergy's other customers have real good sites.
Look at GSK's site for Emergen-C... That stuff sells everywhere, people have no idea it's absolute trash with 3 forms of Sugar, synthetic lab vitamins and heated Ammonia among other stuff, but everybody knows about it.
If Enzolytics' first step into the market is with that site, it will be ugly... They need the front page to say "Why we are different" compared to the 800,000,000 other Immune support supplements and scrap the testimonials...
When it's selling, solicit testimonials and REAL pictures of people... That "Doctor" doesn't turn up in an image search... Have the real people holding a bottle like the GSK site has people holding the Emergen-C.
https://www.emergenc.com/
Obviously ppl don't understand the FDA and the history against this BioTech.
I spoke to Onelavi yesterday about my pending order, the product will be available and orders filled, no doubt about it.
Maybe Charles is going to play SANTA and give us a Christmas present.
Months after not delivering a product that the company actually had a slime bucket website taking orders for, and then saying there is a "labelling issue" is an excuse, not a delay.
Denial has never been a successful investing strategy!
This is another example of why ENZC will be lower next year!
Seems to be a misunderstanding of what a fact vs excuse is… The fact are what have presented as delays ”There will be no answer! Just excuses, correct?”
The names obviously were omitted, doesnt negate the actual information...there are multiple pages of testimonials from using IPF from Rosetta Lifecare that a shareholder has compiled.
Ppl can choose to not believe, but I have taken it many times along with my family and all look forward to buying at our local retailer.
Followers
|
1250
|
Posters
|
|
Posts (Today)
|
2
|
Posts (Total)
|
199685
|
Created
|
01/07/10
|
Type
|
Free
|
Moderators Homebrew Timing101 archilles SeniorApollo |
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |